species- Mus musculus Engineering the mouse genome David Ornitz

Transcription

1 species- Mus musculus Engineering the mouse genome David Ornitz

2 How do we analyze gene function in mice? Gene addition (transgenic approach) Permits GOF, DN and knockdown experiments Ectopic (spatial or temporal) expression Allows gene regulatory elements to be tested Allows populations of cells to be marked with a reporter gene Targeted mutations Specific genes can be targeted Unexpected phenotypes (lethal phenotype may result prior to the spatial and temporal site of interest) Must be very careful to make a null allele Tissue-specific (conditional) targeted mutations Provides some of the best features of gene targeting and transgenic approaches May be combined with enhancer trap and gene trap experiments. An effective method to circumvent embryonic lethality.

3 How do we analyze gene function in mice? Gene addition (transgenic approach) Permits GOF, DN and knockdown experiments Ectopic (spatial or temporal) expression Allows gene regulatory elements to be tested Allows populations of cells to be marked with a reporter gene Targeted mutations Specific genes can be targeted Unexpected phenotypes (lethal phenotype may result prior to the spatial and temporal site of interest) Must be very careful to make a null allele Tissue-specific (conditional) targeted mutations Provides some of the best features of gene targeting and transgenic approaches May be combined with enhancer trap and gene trap experiments. An effective method to circumvent embryonic lethality.

4 How do we analyze gene function in mice? Gene addition (transgenic approach) Permits GOF, DN and knockdown experiments Ectopic (spatial or temporal) expression Allows gene regulatory elements to be tested Allows populations of cells to be marked with a reporter gene Targeted mutations Specific genes can be targeted Unexpected phenotypes (lethal phenotype may result prior to the spatial and temporal site of interest) Must be very careful to make a null allele Tissue-specific (conditional) targeted mutations Provides some of the best features of gene targeting and transgenic approaches May be combined with enhancer trap and gene trap experiments. An effective method to circumvent embryonic lethality.

5 Breeding mice gestation period-19 days (range is days depending on strain) age at weaning-21 days sexual maturity-females 4-5 weeks, males-6-8 weeks birthweight-1 gm weaning-8-12 gm adult gm

6 Preimplantation mouse development

7 Aggregation chimeras Before the use of microinjection aggregation chimeras were the only way to genetically modify cells and test them during mouse development Morula aggregation, used to make chimeras between two different genetic backgrounds ES/EC cell chimera add genetically modified cells to a mouse

8 Routes for Introducing Genes into Mice 1) Microinjection of DNA into zygotes 2) Injection of embryos with recombinant virus 3) Transfection of ES cells with cloned DNA Selection, Characterization Chimera formation Transgenic Mice

9

10 Transgenic Mice: Gene addition Random insertion of DNA into the mouse genome Permits GOF, DN and knockdown experiments Allows gene regulatory elements to be tested Allows populations of cells to be marked with a reporter gene Occasionally allows endogenous genes to be trapped

11 Components of a Transgene promoter + enhancer gene coding sequence or cdna polyadenylation signal promoter cdna splice/poly A Things that are good: introns Things that are bad: plasmid sequence, lack of introns

12 example: Elastase Promoter cell-type specific expression 200 bp is sufficient for expression Pr/En hgh poly A Pr/En v-ras splice/poly A cdna

13 Transgenic mouse issues: Tissue specificity ectopic expression chromosomal integration site may affect expression Temporal specificity Level of expression Insertional mutagenesis

14 How to make a transgenic mouse 1. Fusion Gene Construct 2. Superovulated Female Promoter ATG Coding Sequence p(a) Fertilized Eggs Microinjection 3. Germline Integration 4. DNA Analysis TRANSGENIC MOUSE 5. Breeding

15

16

17

18 Manipulating the Mouse Embryo a laboratory manual, CSHL press from

19

20 Homologous recombination using embryonic stem cells First completely unbiased experiment of gene function in an entire mammalian organism. Discover unanticipated early embryonic roles Potential problems: Embryonic lethality Redundancy

21 Events leading to the development of Embryonic Stem Cells Teratoma tumors composed of various tissues foreign to their site of origin. can be formed by transplanting pieces of embryos to extra uterine sites. Teratocarcinoma undifferentiated malignant stem cells, metastasize, lethal made by transplanting day 6-7 mouse embryos under the kidney capsule resulting tumors can be passaged and cultured to yield embryonal carcinoma cells

22 Embryonic Stem Cells-cont. EC cell lines variety of stages of differentiation and variable capacity to differentiate exponential growth and feeder cells are required to prevent differentiation differentiation can be induced by aggregation differentiation can be induced by drugs, RA or DMSO. ES cells a normal pleuripotent cell line isolated from normal embryo without passing through a tumor stage. when reintroduced into the embryonic environment ES cells can generate high grade chimeras. essential to grow on feeder cells (STO fibroblasts or MEFs). LIF/DIA is required to maintain pleuripotency of ES cells.

23 Establishment of ES cell lines: transfer intact blastocysts into culture grow to stage of early post implantation embryo dissociate embryonic from extraembryonic tissue continue to culture ICM. 2 days after disaggregation of ICM 4 days after disaggregation First passage

24

25 Chimeric mouse ES cells derived from 129/SV strain, agouti coat color injected into a C57/B6 blastocyst. Mate chimeric mouse to Black mouse (C57/B6J) identify agouti offspring

26 Gene Knockout critical X

27 Gene Knockout critical genetic engineering using embryonic stem cells X Mario R. Capecchi Sir Martin J. Evans Oliver Smithies The Nobel Prize in Physiology or Medicine 2007 "for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells"

28 Gene Knockout critical genetic engineering using embryonic stem cells X

29 Practical issues for basic gene targeting: length of homology probes to detect homologous recombination vector design Target gene Targeting vector Targeted allele

30 Targeted mutations gene addition Target gene Targeting vector Targeted allele random integration

31 Issues in interpreting targeted mutations Must be very careful to make a null allele haplotype insufficient recessive Prove that an allele is null gene expression protein expression assay for activity of protein Other types of alleles hypomorphic allele dominant negative linked random mutation - generate multiple ES lines recessive

32 Issues in interpreting targeted mutations Must be very careful to make a null allele haplotype insufficient recessive Prove that an allele is null gene expression protein expression assay for activity of protein Other types of alleles hypomorphic allele dominant negative linked random mutation - generate multiple ES lines recessive

33 Issues in interpreting targeted mutations Must be very careful to make a null allele haplotype insufficient recessive Prove that an allele is null gene expression protein expression assay for activity of protein Other types of alleles hypomorphic allele dominant negative linked random mutation - generate multiple ES lines recessive

34 Xu, X., Weinstein, M., Li, C., Naski, M., Cohen, R. I., Ornitz, D. M., Leder, P., and Deng, C. (1998). Fibroblast growth factor receptor 2 (FGFR2)-mediated regulation loop between FGF8 and FGF10 is essential for limb induction, Development 125, Arman, E., Haffnerkrausz, R., Chen, Y., Heath, J. K., and Lonai, P. (1998). Targeted disruption of fibroblast growth factor (Fgf) receptor 2 suggests a role for fgf signaling in pregastrulation mammalian development, Proc. Natl. Acad. Sci., U S A 95,

35 Issues in interpreting targeted mutations - cont. Neighboring gene effect PGK promoter - neo may influence a nearby gene remove the selection cassette to avoid this potential problem Unexpected phenotype lethal phenotype may result prior to the developmental stage of interest Targeted allele PGK-Neo

36 Cell, Vol. 85, 1 4, April 5, 1996, Copyright 1996 by Cell Press Know Your Neighbors: Three Phenotypes in Null Mutants of the Myogenic bhlh Gene MRF4 E. N. Olson,* H.-H. Arnold, P. W. J. Rigby, and B. J. Wold c

37 Removing the Neo selection cassette critical genetic engineering using embryonic stem cells PGK-NEO loxp loxp flox = flanked by lox X PGK-NEO X

38 Removing the Neo selection cassette critical genetic engineering using embryonic stem cells PGK-NEO loxp loxp flox = flanked by lox X PGK-NEO X

39 Removing the Neo selection cassette critical genetic engineering using embryonic stem cells PGK-NEO loxp loxp flox = flanked by lox X germline promoter - Cre recombinase PGK-NEO X

40 Removing the Neo selection cassette critical genetic engineering using embryonic stem cells PGK-NEO loxp loxp flox = flanked by lox X germline promoter - Cre recombinase X

41 Advanced gene targeting issues Targeting one allele versus both alleles Gene replacement using recombinases Knockin mice

42 Conditional tissue-specific targeted mutations provides some of the best features of gene targeting and transgenic approaches may be combined with enhancer trap and gene trap experiments the targeted gene can be modified using cre and flip recombinases may be used in conjunction with inducible promoters

43 Regulated activation/inactivation of a gene using CreER fusion proteins critical loxp loxp flox = flanked by lox critical X

44 Regulated activation/inactivation of a gene using CreER fusion proteins critical loxp loxp flox = flanked by lox tissue specific promoter - CreER recombinase Cytosol critical X

45 Regulated activation/inactivation of a gene using CreER fusion proteins critical loxp loxp flox = flanked by lox tissue specific promoter - CreER recombinase + tamoxifen nuclear translocation Cytosol critical X

46 Regulated activation/inactivation of a gene using CreER fusion proteins critical loxp loxp flox = flanked by lox tissue specific promoter - CreER recombinase + tamoxifen nuclear translocation Cytosol X

47 EUCOMM gene targeting vector Frt SA-βgeo-PA LoxP PGK -neo Critical 5' hom ology 3' hom ology

48 EUCOMM gene targeting vector Frt SA-βgeo-PA LoxP PGK -neo Critical 5' hom ology 3' hom ology Frt SA-βgeo-PA SA-CreER-PA LoxP PGK -neo Critical 5' hom ology 3' hom ology

49 Mouse Genetic Models Core!!